-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on Mind Medicine, Raises Price Target to $25

Benzinga·11/07/2025 21:51:24
Listen to the news
Canaccord Genuity analyst Sumant Kulkarni maintains Mind Medicine (NASDAQ:MNMD) with a Buy and raises the price target from $16 to $25.